View Older Stories View More Recent Stories
-
Popular stocks with increasing volume: SMCI INTC PLTR BABA HOOD LYFT UBER MSTR CVS
-
CVS Health (CVS) Tops Q4 EPS by 19c, Beats on Revenue; Offers FY25 EPS Guidance
-
CVS Health earnings preview: Analysts eye 2025 guidance and medicare advantage turnaround
-
CVS Health (CVS) PT Lowered to $59 at UBS
-
Edward Jones Upgrades CVS Health (CVS) to Buy
-
CVS Health (CVS) call put ratio 6.8 calls to 1 put as Trump administration pauses assistance program payouts
-
CVS Health (CVS) PT Raised to $55 at Leerink Partners
-
CVS Health (CVS) PT Raised to $65 at Evercore ISI
-
Piper Sandler Highlights CVS Health (CVS) as Top Pick, Reiterates OW
-
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
-
Humana (HUM), Others Gain After Proposal Could Lead to Increased Payments from MA Plans
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 6% Yield
-
House Republicans Are Eyeing A Package To Extend Govt Funding For Three Months - Punchbowl
-
CVS Health (CVS) PT Lowered to $51 at Baird
-
CVS Health (CVS) Prices Maximum Tender Offer
-
Trump on drug industry: We're going to knock out the middle man
-
CVS Health (CVS) call put ratio 1.3 calls to 1 put with focus on February 65 calls as share price down 5%
-
Bipartisan Legislation To Be Introduced to Force Health Insurers to Give Up Pharmacy Businesses -- WSJ
-
CVS Health (CVS) call put ratio 3.4 calls to 1 put with focus on December 13 weekly 57 calls
-
CVS Health (CVS) Looks At Selling Bonds While Offering to Buy Back Debt: Bloomberg
-
CVS Health (CVS) PT Raised to $80 at TD Cowen
-
CVS Health (CVS) PT Lowered to $64 at Piper Sandler
-
CVS Health (CVS) Appoints Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman to its Board
-
CVS Health (CVS) PT Lowered to $57 at Leerink Partners
-
Trump picks RFK Jr for HHS — Here are potential policy implications
-
CVS Health (CVS) PT Lowered to $58 at RBC Capital
-
CVS Health (CVS) Appoints Steve Nelson as President, Aetna
-
CVS Health (CVS) Misses Q3 EPS by 46c, Beats on Revenue
-
CVS Health (CVS) call put ratio 1 call to 1.4 puts with focus on November 8 weekly 55 puts into quarter results
-
CVS Health (CVS) November 8 weekly 55 straddle priced into quarter results
-
CVS Health (CVS) call put ratio 4.5 calls to 1 put with focus on November 8 weekly 53 puts into quarter results
-
The election implications for healthcare technology and distribution stocks - BofA
-
CVS Health (CVS) PT Lowered to $66 at Mizuho
-
Moody's Ratings Reviews CVS's (CVS) Ratings for Downgrade
-
Piper Sandler Reiterates Overweight Rating on CVS Health (CVS)
-
Popular stocks with increasing volume: SMCI COIN TSM BABA CVS OKLO AAL BAC
-
Popular stocks with increasing volume: SMCI COIN TSM BABA CVS OKLO AAL BAC
-
CVS Health (CVS) call put ratio 1.3 calls to 1 put as share price down 8%
-
Stocks expected to have increasing option volume: CVS WBA LW USM BA SPR
-
CVS Health (CVS) -11% on warning, new CEO
-
CVS Health (CVS) provides preliminary guidance for Q3, Adjusted EPS of $1.05 to $1.10, vs $1.70 cons
-
CVS Health (CVS) Appoints David Joyner as CEO
-
CVS to report third-quarter results that will fall short of market expectations- WSJ
-
CVS Health (CVS) Names David Joyner as New Chief Executive- WSJ
-
CVS Health (CVS) introduces SimplePay Health
-
CVS Health (CVS) report explores ongoing transformation of community pharmacy
-
TD Cowen Reiterates Buy Rating on CVS Health (CVS)
-
CVS Health (CVS) call put ratio 4.9 calls to 1 put with focus on October 65 calls, November 1 weekly 69 calls and January 70 calls
-
Barclays Upgrades CVS Health (CVS) to Overweight
-
CVS Health (CVS) call put ratio 1.8 calls to 1 put
